Reissuing the sigma receptors for SARS-CoV-2.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Accurate prediction of virus-host protein-protein interactions via a Siamese neural network using deep protein sequence embeddings.Patterns (New York, N.Y.) · 2022
   Article
2. Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution.Frontiers in psychiatry · 2022
   Article
3. Psychotropics and COVID-19: An analysis of safety and prophylaxis.L'Encephale · 2021
   Article
4. Psychotic Agitation in a Patient with COVID-19: Pathogenesis or Iatrogenesis?Psychiatry and clinical psychopharmacology · 2021
   Article
5. Considerations of the effects of commonly investigated drugs for COVID-19 in the cholesterol synthesis pathway.Expert opinion on pharmacotherapy · 2021
   Article
6. SARS-CoV-2-associated first episode of acute mania with psychotic features.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021
   Article
7. Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.European archives of psychiatry and clinical neuroscience · 2021
   Review
8. Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19.Frontiers in pharmacology · 2021
   Article
9. Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort.In vivo (Athens, Greece)
   Article

Corrections and comments

• Comment on
  How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of Sapienza University, Italy.2020

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as